Total raised in public, private and other financings of biopharma companies, comparing 2019-2024.

Year-to-date money raised in public, private and other financings of biopharma companies.

BioWorld MedTech briefs for December 27, 2024.

Biopharmas raising money in public or private financings, including: Carmell, Gemmabio, Os, Polypid.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Daiichi Sankyo, Hikma, Sumitomo.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Achilles, Astrazeneca, Bionomics, Bio-Thera, City of Hope, Enanta, Fuse-AI, Heron, Johnson & Johnson, Neuphoria, Pfizer, Tabuk, Xlife.

Med-tech firms raising money in public or private financings, including: Inspira.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Medinol, Microtech, Navigantis.

BioWorld briefs for Dec. 27, 2024.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Applied, Astrazeneca, Bristol Myers, Eli Lilly, Glaukos, Keymed, Novo Nordisk, Nuvation, Pfizer, Rhythm, Tonix, Vertex.